Biotechnology - UK, Respiratory and Pulmonary

Filter

Popular Filters

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

ERS 2014: Encouraging new data with AstraZeneca’s benralizumab

08-09-2014

Anglo-Swedish drug major AstraZeneca today announced that The Lancet Respiratory Medicine has published…

AstraZenecabenralizumabBiotechnologyCOPDGermanyHealth Medical PharmaPulmonologyResearchRespiratory and PulmonaryRespiratory therapyUK

AstraZeneca licensing deal validates Synairgen’s approach, say analysts

AstraZeneca licensing deal validates Synairgen’s approach, say analysts

14-07-2014

Anglo-Swedish drug major AstraZeneca’s recent $230 million deal with British respiratory drug development…

AsthmaAstraZenecaBiotechnologyInterferonLicensingRespiratory and PulmonaryRespiratory therapySNG001SynairgenUK

Ario Pharma strengthens scientific advisory board with two key appointments

Ario Pharma strengthens scientific advisory board with two key appointments

12-05-2014

UK-based biopharmaceutical company Ario Pharma has announced the appointment of Professor Peter Barnes…

BiotechnologyBoardroomPharmaceuticalRespiratory and PulmonaryUK

COMPANY SPOTLIGHT

Menarini

Back to top